InChI=1S/C19H23NO5/c1-21-17-8-5-9-18(22-2)19(17)23-11-10-20-12-14-13-24-15-6-3-4-7-16(15)25-14/h3-9,14,20H,10-13H2,1-2H3 |
GYSZUJHYXCZAKI-UHFFFAOYSA-N |
COc1cccc(OC)c1OCCNCC1COc2ccccc2O1 |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
alpha-adrenergic antagonist
An agent that binds to but does not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous alpha-adrenergic agonists. alpha-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
|
|
alpha-adrenergic antagonist
An agent that binds to but does not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous alpha-adrenergic agonists. alpha-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
|
|
View more via ChEBI Ontology
Outgoing
|
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
(CHEBI:64098)
has role
α-adrenergic antagonist
(CHEBI:37890)
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
(CHEBI:64098)
is a
aromatic ether
(CHEBI:35618)
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
(CHEBI:64098)
is a
benzodioxine
(CHEBI:64096)
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
(CHEBI:64098)
is a
secondary amino compound
(CHEBI:50995)
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
(CHEBI:64098)
is conjugate base of
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanaminium(1+)
(CHEBI:64097)
|
|
Incoming
|
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanaminium(1+)
(CHEBI:64097)
is conjugate acid of
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
(CHEBI:64098)
|
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
|
(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane
|
ChemIDplus
|
(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzodioxan
|
ChemIDplus
|
N-(2-(2,6-Dimethoxyphenoxy)ethyl)-2,3-dihydro-1,4-benzodioxin-2-methanamine
|
ChemIDplus
|
WB 4101
|
ChemIDplus
|
WB-4101
|
ChemIDplus
|
WB4101
|
ChemIDplus
|
4206776
|
Reaxys Registry Number
|
Reaxys
|
18850495
|
PubMed citation
|
Europe PMC
|
19041301
|
PubMed citation
|
Europe PMC
|
19114413
|
PubMed citation
|
Europe PMC
|
19463264
|
PubMed citation
|
Europe PMC
|
19686710
|
PubMed citation
|
Europe PMC
|
20450248
|
PubMed citation
|
Europe PMC
|
20554480
|
PubMed citation
|
Europe PMC
|
20862454
|
PubMed citation
|
Europe PMC
|
21146475
|
PubMed citation
|
Europe PMC
|
21219971
|
PubMed citation
|
Europe PMC
|
21475142
|
PubMed citation
|
Europe PMC
|
21535246
|
PubMed citation
|
Europe PMC
|
22179423
|
PubMed citation
|
Europe PMC
|
7901775
|
PubMed citation
|
Europe PMC
|
|